| Trial ID: | L3212 |
| Source ID: | NCT00699686
|
| Associated Drug: |
Glargine
|
| Title: |
Endothelial Effects of Basal Insulin: Detemir Versus Glargine
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Endothelial Dysfunction|Cardiovascular Disease
|
| Interventions: |
DRUG: Glargine|DRUG: Detemir
|
| Outcome Measures: |
Primary: Change in endothelial progenitor cell count, Basal, 3 months, 6 months | Secondary: Change in markers of endothelial damage, Basal, 3 months, 6 months|Frequence of hypoglycemias, The frequency of hypoglycemia will be reported for patients on glargine or detemir during the 1st and 2nd period of treatment., during 1st and 2nd arms|Change in body weight, Change in body weight will be assessed after each arm during treatment with glargine or detemir, After the 1st and 2nd arms
|
| Sponsor/Collaborators: |
Sponsor: University of Padova
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2010-03
|
| Results First Posted: |
|
| Last Update Posted: |
2010-08-17
|
| Locations: |
Dipartimento di Medicina Clinica e Sperimentale, Divisione di Malattie del Metabolismo, Padova, 35100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00699686
|
